Benjamin M. Wohl

524 total citations
15 papers, 455 citations indexed

About

Benjamin M. Wohl is a scholar working on Molecular Biology, Infectious Diseases and Biomaterials. According to data from OpenAlex, Benjamin M. Wohl has authored 15 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Infectious Diseases and 3 papers in Biomaterials. Recurrent topics in Benjamin M. Wohl's work include HIV/AIDS drug development and treatment (8 papers), Biochemical and Molecular Research (7 papers) and RNA Interference and Gene Delivery (4 papers). Benjamin M. Wohl is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Biochemical and Molecular Research (7 papers) and RNA Interference and Gene Delivery (4 papers). Benjamin M. Wohl collaborates with scholars based in Denmark, Australia and Germany. Benjamin M. Wohl's co-authors include Johan F. J. Engbersen, Alexander N. Zelikin, Anton A. A. Smith, Kaja Zuwała, Martin Tolstrup, Pau Ruiz‐Sanchis, Almar Postma, Carlos Guerrero‐Sánchez, María Godoy‐Gallardo and Leticia Hosta‐Rigau and has published in prestigious journals such as Chemical Communications, Journal of Controlled Release and Biomacromolecules.

In The Last Decade

Benjamin M. Wohl

15 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin M. Wohl Denmark	12	164	128	120	113	113	15	455
Cody J. Higginson United States	11	176 1.1×	95 0.7×	57 0.5×	154 1.4×	115 1.0×	18	604
Camilla Kaas Frich Denmark	13	182 1.1×	84 0.7×	18 0.1×	78 0.7×	105 0.9×	16	409
Kulachart Jangpatarapongsa Thailand	15	195 1.2×	106 0.8×	21 0.2×	46 0.4×	177 1.6×	45	573
Selvi Srinivasan United States	16	257 1.6×	141 1.1×	23 0.2×	99 0.9×	138 1.2×	25	547
Hua-fen Wang China	13	281 1.7×	190 1.5×	21 0.2×	133 1.2×	173 1.5×	21	578
Mai N. Vu Australia	9	124 0.8×	119 0.9×	39 0.3×	84 0.7×	102 0.9×	16	378
Ken‐ichiro Hiwatari Japan	15	304 1.9×	171 1.3×	56 0.5×	90 0.8×	88 0.8×	30	608
Ryan M. Flessner United States	9	181 1.1×	63 0.5×	124 1.0×	144 1.3×	66 0.6×	10	510
Al Halifa Soultan Canada	12	225 1.4×	132 1.0×	11 0.1×	131 1.2×	89 0.8×	19	578
Kaja Zuwała Denmark	14	140 0.9×	58 0.5×	9 0.1×	100 0.9×	54 0.5×	17	407

Countries citing papers authored by Benjamin M. Wohl

Since Specialization

Citations

This map shows the geographic impact of Benjamin M. Wohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin M. Wohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin M. Wohl more than expected).

Fields of papers citing papers by Benjamin M. Wohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin M. Wohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin M. Wohl. The network helps show where Benjamin M. Wohl may publish in the future.

Co-authorship network of co-authors of Benjamin M. Wohl

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin M. Wohl. A scholar is included among the top collaborators of Benjamin M. Wohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin M. Wohl. Benjamin M. Wohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hinton, Tracey M., Kaja Zuwała, Céline Deffrasnes, et al.. (2016). Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity. Advanced Healthcare Materials. 5(5). 534–540. 10 indexed citations

Wohl, Benjamin M., et al.. (2015). Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugs. Chemical Communications. 52(5). 889–891. 5 indexed citations

Godoy‐Gallardo, María, Pramod Kumar Ek, Michelle Maria Theresia Jansman, Benjamin M. Wohl, & Leticia Hosta‐Rigau. (2015). Interaction between drug delivery vehicles and cells under the effect of shear stress. Biomicrofluidics. 9(5). 52605–52605. 25 indexed citations

Wohl, Benjamin M., Anton A. A. Smith, Bettina E. B. Jensen, & Alexander N. Zelikin. (2014). Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation. Journal of Controlled Release. 196. 197–207. 15 indexed citations

Smith, Anton A. A., Kaja Zuwała, Benjamin M. Wohl, et al.. (2014). Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV. Chemical Science. 6(1). 264–269. 26 indexed citations

Kock, Anders, Kaja Zuwała, Anton A. A. Smith, et al.. (2014). Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs. Chemical Communications. 50(93). 14498–14500. 29 indexed citations

Ruiz‐Sanchis, Pau, Benjamin M. Wohl, Anton A. A. Smith, et al.. (2014). Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host Cells. Advanced Healthcare Materials. 4(1). 65–68. 26 indexed citations

Smith, Anton A. A., Benjamin M. Wohl, Pau Ruiz‐Sanchis, et al.. (2014). Macromolecular (pro)drugs in antiviral research. Polymer Chemistry. 5(22). 6407–6425. 33 indexed citations

Smith, Anton A. A., et al.. (2014). Drug Delivery: Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the Drug (Adv. Healthcare Mater. 9/2014). Advanced Healthcare Materials. 3(9). 1520–1520. 1 indexed citations

10.

Smith, Anton A. A., et al.. (2014). Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the Drug. Advanced Healthcare Materials. 3(9). 1404–1407. 22 indexed citations

11.

Wohl, Benjamin M., et al.. (2013). Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug. Chemical Communications. 49(26). 2643–2643. 31 indexed citations

12.

Wohl, Benjamin M., et al.. (2013). Narrow Therapeutic Window of Ribavirin as an Inhibitor of Nitric Oxide Synthesis is Broadened by Macromolecular Prodrugs. Biomacromolecules. 14(11). 3916–3926. 23 indexed citations

13.

Smith, Anton A. A., et al.. (2013). Macromolecular Prodrugs for Controlled Delivery of Ribavirin. Macromolecular Bioscience. 14(2). 173–185. 18 indexed citations

14.

Chong, Siow‐Feng, et al.. (2013). Poly(vinyl alcohol) Physical Hydrogel Nanoparticles, Not Polymer Solutions, Exert Inhibition of Nitric Oxide Synthesis in Cultured Macrophages. Biomacromolecules. 14(5). 1687–1695. 14 indexed citations

15.

Wohl, Benjamin M. & Johan F. J. Engbersen. (2011). Responsive layer-by-layer materials for drug delivery. Journal of Controlled Release. 158(1). 2–14. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact